USANA Health Sciences, Inc. (USNA) Director Sells $781,938.45 in Stock
USANA Health Sciences, Inc. (NYSE:USNA) Director Myron W. Wentz sold 11,835 shares of the stock in a transaction dated Wednesday, November 15th. The stock was sold at an average price of $66.07, for a total transaction of $781,938.45. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
USANA Health Sciences, Inc. (NYSE USNA) traded up $0.15 during trading on Thursday, hitting $66.00. 136,493 shares of the stock were exchanged, compared to its average volume of 128,351. The stock has a market capitalization of $1,582.31, a price-to-earnings ratio of 17.45 and a beta of 1.07. USANA Health Sciences, Inc. has a one year low of $52.55 and a one year high of $71.00.
USANA Health Sciences (NYSE:USNA) last posted its earnings results on Tuesday, October 24th. The company reported $1.02 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.91 by $0.11. The company had revenue of $261.77 million during the quarter, compared to analyst estimates of $259.52 million. USANA Health Sciences had a net margin of 8.79% and a return on equity of 26.38%. USANA Health Sciences’s revenue for the quarter was up 3.0% on a year-over-year basis. During the same period in the prior year, the business posted $2.40 earnings per share. equities research analysts forecast that USANA Health Sciences, Inc. will post 3.7 EPS for the current year.
USANA Health Sciences announced that its Board of Directors has approved a stock buyback program on Tuesday, July 25th that authorizes the company to repurchase $64.60 million in shares. This repurchase authorization authorizes the company to repurchase up to 46% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s board of directors believes its stock is undervalued.
TRADEMARK VIOLATION NOTICE: “USANA Health Sciences, Inc. (USNA) Director Sells $781,938.45 in Stock” was published by American Banking News and is owned by of American Banking News. If you are viewing this report on another domain, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright legislation. The original version of this report can be accessed at https://www.americanbankingnews.com/2017/11/16/usana-health-sciences-inc-usna-director-sells-781938-45-in-stock.html.
Institutional investors and hedge funds have recently modified their holdings of the business. BNP Paribas Arbitrage SA lifted its holdings in USANA Health Sciences by 13.1% in the second quarter. BNP Paribas Arbitrage SA now owns 2,111 shares of the company’s stock worth $135,000 after buying an additional 245 shares during the period. Victory Capital Management Inc. lifted its holdings in USANA Health Sciences by 17.6% in the second quarter. Victory Capital Management Inc. now owns 2,490 shares of the company’s stock worth $160,000 after buying an additional 373 shares during the period. Creative Planning lifted its holdings in USANA Health Sciences by 528.0% in the second quarter. Creative Planning now owns 2,512 shares of the company’s stock worth $161,000 after buying an additional 2,112 shares during the period. SG Americas Securities LLC purchased a new stake in USANA Health Sciences in the second quarter worth about $162,000. Finally, Cubist Systematic Strategies LLC purchased a new stake in USANA Health Sciences in the third quarter worth about $189,000. Institutional investors and hedge funds own 44.54% of the company’s stock.
USNA has been the subject of a number of analyst reports. Pivotal Research increased their target price on shares of USANA Health Sciences from $70.00 to $80.00 and gave the stock a “buy” rating in a report on Wednesday, October 25th. BidaskClub upgraded shares of USANA Health Sciences from a “sell” rating to a “hold” rating in a report on Thursday, October 26th.
USANA Health Sciences Company Profile
USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.
Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.